Cancer Drugs Fund: Life-extending drugs to be denied to NHS patients in England as fund overspends, The Independent

PDF) Scoping Review of International Experience of a Dedicated

Keep Kadcyla

NHS spends nearly £500m on cancer drugs developed with public

NHS Can't Afford Half of New Cancer Drugs - Dying for a Cure

UK newspaper reporting of the NHS cancer drugs fund, 2010 to 2015

PDF) Do patient access schemes for high-cost cancer drugs deliver

The merry-go-round of approval, pricing and reimbursement of drugs

NHS is failing patients, cancer charities warn after life-saving

cure leukaemia Access CML Drugs

NHS Can't Afford Half of New Cancer Drugs - Dying for a Cure

Mismanagement of Cancer Drugs Fund unacceptable - PMLiVE

UK newspaper reporting of the NHS cancer drugs fund, 2010 to 2015

PDF) Market access of cancer drugs in European countries

PDF) Do patient access schemes for high-cost cancer drugs deliver